F-Prime Capital logo

F-Prime Capital

Crunchbase
Pitchbook
Crunchbase

Deals on record

24

Common Fundraising Type

Series A

RhyGaze logo
RhyGaze

Gene therapy

GV logo
Novartis logo
F-Prime Capital logo
BioGeneration Ventures logo
Arch Venture Partners logo

RhyGaze is a biotechnology company developing gene therapies for vision restoration in retinal diseases.

Series A
$86M
01/10/2025
Article
Leyden Labs logo
Leyden Labs

Mucosal Protection

ClavystBio logo
Qiming Venture Partners logo
Polaris Partners logo
GV logo
Casdin Capital logo
F-Prime Capital logo
Invus logo
Byers Capital logo

Leyden Labs develops non-vaccine intranasal antibody treatments to protect against respiratory viruses like influenza and coronaviruses.

Equity
$70M
01/09/2025
Article
Tenvie Therapeutics logo
Tenvie Therapeutics

Biotechnology

Mubadala Capital logo
F-Prime Capital logo
ARCH Venture Partners logo

Tenvie Therapeutics is a biotechnology company developing small molecule therapeutics for neurological, cardiometabolic, and ophthalmic diseases.

Equity
$200M
01/08/2025
Article
TripSuite logo
TripSuite

AI-powered

F-Prime Capital logo
Thayer Ventures logo
Bienville Capital Management logo

TripSuite provides an AI-powered software platform that streamlines workflows and improves efficiency for travel agencies by integrating CRM, commission tracking, accounting, and analytics.

Seed
$5M
12/19/2024
Article
nChroma Bio logo
nChroma Bio

Epigenetic editing

Wilson Sonsini Goodrich & Rosati logo
Wellington Management logo
T. Rowe Price logo
Sofinnova Partners logo
Sixth Street logo
Omega Funds logo
Mubadala Capital logo
Menlo Ventures logo

nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.

Equity
$75M
12/11/2024
Article

Albert Invent provides an AI-driven platform to optimize chemical R&D processes, offering tools like real-time toxicology predictions and molecular property forecasting for chemists.

Series A
$22.5M
12/11/2024
Article
Zenflow logo
Zenflow

Medical device

Medical Technology Venture Partners logo
Invus Opportunities logo
F-Prime Capital logo
Cook Medical logo

Zenflow, Inc. develops minimally invasive medical devices for treating urinary obstruction caused by benign prostatic hyperplasia (BPH).

Series C
$24M
11/18/2024
Article
Notabene logo
Notabene

Crypto

Y Combinator logo
Wintermute logo
Signature Ventures logo
Nextblock logo
ParaFi Capital logo
Jump Capital logo
Illuminate Financial logo
Green Visor Capital logo

Notabene provides a platform for crypto anti-money laundering compliance, helping companies adhere to global AML regulations like the Financial Action Task Force's "Travel Rule."

Series B
$14.5M
11/12/2024
Article
AvenCell logo
AvenCell

Cell therapy

Novo Holdings logo
F-Prime Capital logo
NYBC Ventures logo
Piper Heartland Healthcare Capital logo
Eight Roads Ventures Japan logo
Blackstone Life Sciences logo

AvenCell Therapeutics, Inc. develops a Universal Switchable CAR-T cell therapy platform for treating hematologic malignancies and autoimmune diseases.

Series B
$112M
10/22/2024
Article

Shift Bioscience is a biotech company that uses an AI-driven cell simulation platform to identify rejuvenation genes for developing therapeutics for age-related diseases.

Seed
$16.3M
10/15/2024
Article

SPRY Therapeutics provides an AI-driven SaaS platform for physical therapy professionals to manage clinics, enhance billing, and improve patient engagement.

Equity
$15M
10/11/2024
Article
Rippl logo
Rippl

Virtual dementia care

Kin Ventures logo
Mass General Brigham Ventures logo
JSL Health logo
GV logo
General Catalyst logo
F-Prime logo
ARCH Venture Partners logo
1843 Capital logo

Rippl is a virtual dementia care company focused on providing tech-driven care solutions and expanding its network of healthcare providers for senior-focused behavioral health.

Series A
$23M
10/09/2024
Article
Centivo logo
Centivo

Healthcare

Trinity Capital logo
Morgan Health logo
MemorialCare logo
Ingleside Investors logo
F-Prime Capital logo
Cone Health Ventures logo
Cox Enterprises logo
B Capital logo

Centivo is a healthcare company focused on making high-quality healthcare more affordable for employers and their employees by reducing out-of-pocket costs.

Hybrid
$75M
09/26/2024
Article
Quantum Circuits logo
Quantum Circuits

Quantum computers

Tribeca Venture Partners logo
Tao Capital Partners logo
Sequoia Capital logo
Osage University Partners logo
In-Q-Tel logo
Hither Creek Ventures logo
Fitz Gate Ventures logo
F-Prime Capital logo

Quantum Circuits develops high-fidelity quantum computers with intrinsic error detection and handling.

Series B
$60M
08/16/2024
Article
Chaos Labs logo
Chaos Labs

Onchain

Wintermute Ventures logo
Spartan Capital logo
Slow Ventures logo
PayPal Ventures logo
Lightspeed Venture Partners logo
Haun Ventures logo
General Catalyst logo
Galaxy Ventures logo

Chaos Labs is an NYC-based company that provides onchain risk management and economic security for crypto protocols.

Series A
$55M
08/16/2024
Article

Shinobi Therapeutics is a biotech company developing off-the-shelf, immune-evasive, induced pluripotent stem cell (iPSC)-derived cell therapies for GPC3+ solid tumor cancers.

Series A
$51M
12/12/2023
Article
ARTBIO logo
ARTBIO

Radiopharmaceuticals

Third Rock Ventures logo
Omega Funds logo
F-Prime Capital logo

ARTBIO is a clinical-stage biotech firm specializing in developing alpha radioligand therapies for cancer treatment, currently advancing its proprietary technology and lead prostate cancer program through clinical trials.

Series A
$90M
12/07/2023
Article

T-Therapeutics is a biotech firm specializing in developing TCR therapeutics for cancer and inflammatory disorders using their proprietary OpTiMus® platform.

Series A
$59.6M
11/16/2023
Article
Eleos Health logo
Eleos Health

AI in Behavioral Health

Menlo Ventures logo
SamsungNEXT logo
lool ventures logo
ION logo
F-Prime Capital logo
Eight Roads logo
Arkin Digital Health logo
aMoon logo

Eleos Health specializes in CareOps Automation, using AI to automate documentation and clinical insights for behavioral health conversations, aiming to reduce operational burden on providers and improve care quality.

Series B
$40M
11/08/2023
Article
Warmly logo
Warmly

Sales leads

Zoom Ventures logo
NFX logo
Maven Ventures logo
F-Prime Capital logo
Felicis logo

Warmly is an autonomous sales platform that uses intent data to identify and connect with potential customers, providing warm leads for sales departments.

Series A
$11M
10/19/2023
Article
Avalyn Pharma logo
Avalyn Pharma

Biopharmaceutical

Perceptive Xontogeny Venture Funds logo
Wellington Management logo
Vida Ventures logo
T. Rowe Price Associates logo
SR One logo
Rock Springs Capital logo
RiverVest Venture Partners logo
Pivotal bioVenture Partners logo

Avalyn Pharma is a biopharmaceutical company that develops inhalation therapies for rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases, with a focus on creating new inhaled formulations of approved medicines.

Series C
$175M
09/27/2023
Article
Doceree logo
Doceree

Healthcare Communications

Creaegis logo
Eight Roads Ventures logo
F-Prime Capital logo

Doceree is a global network that provides programmatic messaging platforms exclusively for physicians, enabling pharmaceutical and life sciences companies and healthcare media agencies to reach healthcare professionals within their digital workflows, and introduce solutions to improve patient health outcomes.

Series B
$35M
09/27/2023
Article
Adela logo
Adela

Blood Testing

RA Capital Management logo
OrbiMed logo
Labcorp logo
F-Prime Capital logo
Deerfield Management logo
Decheng Capital logo

Adela is a healthcare technology company that specializes in blood testing for early cancer detection and minimal residual disease monitoring using a genome-wide methylome enrichment platform.

Equity
$48M
09/26/2023
Article
Better Life Partners logo
Better Life Partners

Healthcare Technology

aMoon logo
F-Prime Capital logo
.406 Ventures logo

Better Life Partners is a Boston-based healthcare company that provides a technology-enabled care model for individuals with substance use disorders, offering services such as specialty treatment, mental and physical healthcare, and care coordination.

Series B
$26.5M
08/29/2023
Article